Axcelis has a focused ion-implant franchise, a sizable installed-base service layer, strong cash and investment liquidity, and Veeco optionality. The hard part is that power and mature-node digestion have pulled revenue down, backlog is lower, export controls matter, and the next leg needs memory strength to become orders instead of just commentary.
The valuation workbench is hidden from non-admin users until market-data licensing and trust disclosures are production-ready.
